Dihydrochalcone derivatives which are hypoglycemic agents

Details Dihydrochalcone derivatives which are hypoglycemic agents Dihydrochalcone derivatives which are hypoglycemic agents

1993-11-10

1995-06-13

Robinson, Douglas W.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536120, C07H 704, C07H 1504, A61K 3170

Patent

active

054244064

ABSTRACT:
A method for treatment of diabetes, which comprises administering to a patient with diabetes an effective amount of a dihydrochalcone derivative of the formula: ##STR1## wherein Ar is an aryl group, R.sup.1 is a hydrogen atom or an acyl group, R.sup.2 is a hydrogen atom, an acyl group or .alpha.-D-glucopyranosyl group, or R.sup.1 and R.sup.2 may combine together to form a substituted methylene group, R.sup.3 and R.sup.4 are each a hydrogen atom or an acyl group, OR.sup.5 is a protected or unprotected hydroxy group or a lower alkoxy group; or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 3984394 (1976-10-01), Westall et al.
patent: 4031260 (1977-06-01), Westall et al.
patent: 4665058 (1987-05-01), Diedrich et al.
patent: 4684627 (1987-08-01), Leveen et al.
patent: 4760135 (1988-07-01), Diedrich et al.
patent: 4840939 (1989-06-01), Leveen et al.
patent: 5110801 (1992-05-01), Leveen et al.
Effect of a Synthetic Dihydrochalcone Sweetener (Chinoin-401) on Carbohydrate Metabolism, P. Pzabo et al., Acta Alimentaria, vol. 11 (1). pp. 31-37.
Hyperglycaemia as an inducer as well as a consequence of impared islet cell function and insulin resistance: implications for the management of Diabetes, Diabetologia, 28 (1985), 119-121.
Guidelines for Toxicity Studies of Drugs, Guidelines for Non-Clinical Test of Drugs, Ministry of Health and Welfare of Japan, 114-118.
Characterization of New Oral Antidiabetic Agent CS-045, T. Fujiwara et al., Diabetes, 37, (1988).
Dorland's Medical Dictionary, 27 ed., pp. 460-461 (1988).
Antiobesity and antidiabetic actions of a new potent disaccharidase inhibtor in genetically obese-kiabetic mice, KKA(y), H. Odaka et al., J. Nutr Sci Vitaminol, 38 (1992), Abstract.
D. Diedrich (1963) Biochim. Biophys. Acta, (71) 688-700.
Rosetti et al. (1990) Diabetes Care 13(6), 610-630.
Rosetti et al. (1987) J. Clin. Invest. (79) 1510-1515.
Rosetti et al. (1987) J. Clin. Invest. (80) 1037-1044.
Kahn et al. (1991) J. Clin. Invest. (87) 561-570.
Unger et al. (1985) Diabetologia 28:119-121.
Oldendorf et al. (1983) Stroke (14) 388-393.
Winget et al. (1969) Biochemistry (8) 2067-2074.
Vick et al. (1973) Am. Journal of Physiology 224(3) 552-557.
D. Diedrich (1966) Ar. of Biochem. and Biophy. 117: 248-256.
Evans et al. (1980) Ar of Biochem. and Biophy. 199(2)342-348.
Bode et al. (1972) Biochem. Biophys. Acta, 290 134-149.

Affiliated with

Also associated with

Rating

Dihydrochalcone derivatives which are hypoglycemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydrochalcone derivatives which are hypoglycemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydrochalcone derivatives which are hypoglycemic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1310165